Data Driven Bioscience GTM brain

category

market profile

• text: Cancer molecular profiling often involves multiple assays and delayed send-outs; Duoseq positions on speed and consolidated testing.
• text: Lymphoma diagnostic validation is a focus, with DNA and RNA sequencing used together.

personas

• title: Molecular pathology laboratory director
  pains:

  • Send-out delays and multiple assays slow reports
  • Limited biopsy tissue must serve many tests
  • Workflow and regulatory integration require proof
• title: Oncologist or hematologist
  pains:

  • Waiting for molecular results can delay treatment decisions
  • Separate reports make a complete tumor profile harder to interpret
• title: Biopharma translational research lead
  pains:

  • Needs combined genomic and expression data to characterize tumors
  • Must coordinate tissue and analysis across studies

icp

• text: Hospital molecular pathology laboratories with sequencing capacity and cancer testing volume are a likely fit.
• text: Cancer centers treating blood cancers and biopharma teams conducting oncology research are plausible targets.

message pillars

• text: Accelerate diagnosis with a two-day sample-to-report workflow.
• text: Combine DNA and RNA from one sample to conserve tissue and simplify work.
• text: Keep testing local to avoid shipping delays.

objections

• objection: Will it work in our clinical lab?
  response: Review validation, instrument compatibility, local workflow and regulatory requirements with the team before adoption.
• objection: Can it fit our existing information systems?
  response: The site claims EPIC and other EHR integration; verify the specific implementation and interfaces.

competitors

• name: Foundation Medicine
  why: Provides cancer genomic profiling, an alternative to parts of the molecular diagnostic workflow.
• name: Tempus
  why: Provides DNA and RNA tumor profiling, competing for oncology testing needs.

keywords

• lymphoma genomic profiling
• DNA RNA cancer sequencing
• molecular pathology testing
• rapid cancer genomics
• oncology NGS assay
• blood cancer molecular diagnosis

voice

• clinical and direct
• speed and workflow focused

signals

• text: A laboratory is bringing oncology sequencing in-house or replacing send-out workflows.
• text: A cancer center is expanding lymphoma molecular diagnostics or reducing turnaround time.

stack

• EPIC EHR

hiring

• Bioinformatics/Biostatistics specialist

pricing

motion

confidence

Founders

• name: Sandeep Dave
  title: Founder
  role: Founder